Jonathan Larkin

2.4k citations

45 papers · 1.4k indexed · 1 hit paper · h-index 22

Impact in

Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
Hepatology top 5%
- Hepatitis C virus research

Papers in ⓘ

Rheumatology 28
- Osteoarthritis Treatment and Mechanisms 26
- Rheumatoid Arthritis Research and Therapies 10
Complementary and Manual Therapy 2

Co-authors: Ali Mobasheri (16 shared papers)Anne‐Christine Bay‐Jensen (17 shared papers)Cojen Ho (4 shared papers)Mary Beth Kelly (4 shared papers)Mark D. Yeager (4 shared papers)Simon J. Slater (4 shared papers)Christopher D. Stubbs (4 shared papers)Frank J. Taddeo (3 shared papers)
Journals: Osteoarthritis and Cartilage (14 papers)Journal of Biological Chemistry (4 papers)Annals of the Rheumatic Diseases (3 papers)Matrix Biology (2 papers)Journal of Interferon & Cytokine Research (2 papers)
Partner nations: United States Denmark United Kingdom

In The Last Decade

Jonathan Larkin

43 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Osteoarthritis endotype discovery via clustering of biochemical marker data 2022 · 97 citations

Peers

Countries citing papers authored by Jonathan Larkin

Since Specialization

Citations

This map shows the geographic impact of Jonathan Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Larkin more than expected).

Fields of papers citing papers by Jonathan Larkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Larkin. The network helps show where Jonathan Larkin may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Larkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Larkin Line = papers co-authored together Jonathan Larkin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Osteoarthritis Year in Review 2016: biomarkers (biochemical markers) Osteoarthritis and Cartilage ·Ali Mobasheri, Anne‐Christine Bay‐Jensen, W.E. van Spil, Jonathan Larkin, Marc C. Levesque	2017	123
2	Protein Kinase Cα Contains Two Activator Binding Sites That Bind Phorbol Esters and Diacylglycerols with Opposite Affinities Journal of Biological Chemistry ·Simon J. Slater, Cojen Ho, Mary Beth Kelly, Jonathan Larkin, Frank J. Taddeo, Mark D. Yeager, Christopher D. Stubbs	1996	110
3	Direct Activation of Protein Kinase C by 1α,25-Dihydroxyvitamin D3 Journal of Biological Chemistry ·Simon J. Slater, Mary Beth Kelly, Frank J. Taddeo, Jonathan Larkin, Mark D. Yeager, John A. McLane, Cojen Ho, Christopher D. Stubbs	1995	109
4	Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification Osteoarthritis and Cartilage ·Jonathan Larkin, Tessa Lohr, Louis Elefante, Jean Shearin, Rosalie Matico, Jing Su, Yu Xue, F. Liu, Caroline A. Genell, Rachel E. Miller, Phuong B. Tran, Anne‐Marie Malfait, Curtis C. Maier, Christopher Matheny	2015	103
5	Osteoarthritis endotype discovery via clustering of biochemical marker data Annals of the Rheumatic Diseases ·Federico Angelini, Paweł Widera, Ali Mobasheri, Joseph Blair, André Struglics, Mélanie Uebelhoer, Yves Henrotin, Anne CA Marijnissen, M. Kloppenburg, Francisco J. Blanco, I.K. Haugen, Francis Bérenbaum, C. Ladel, Jonathan Larkin, Anne‐Christine Bay‐Jensen, Jaume Bacardit Hit paper breakdown →	2022	97
6	Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes Current Opinion in Rheumatology ·Ali Mobasheri, W.E. van Spil, Emma Budd, Ilona Uzielienè, Eiva Bernotienė, Anne‐Christine Bay‐Jensen, Jonathan Larkin, Marc C. Levesque, Oreste Gualillo, Yves Henrotin	2018	87
7	Interaction of Alcohols and Anesthetics with Protein Kinase Cα Journal of Biological Chemistry ·Simon J. Slater, Mary Beth Kelly, Jonathan Larkin, Cojen Ho, Anthony Mazurek, Frank J. Taddeo, Mark D. Yeager, Christopher D. Stubbs	1997	78
8	Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis Osteoarthritis and Cartilage ·Rachel E. Miller, Phuong Bich Tran, Shingo Ishihara, Jonathan Larkin, Anne‐Marie Malfait	2015	62
9	Hepatitis B virus transgenic mouse model of chronic liver disease Nature Medicine ·Jonathan Larkin, Marcy Clayton, Bill Sun, Claire E. Perchonock, Judith L. Morgan, Linda D. Siracusa, Frank H. Michaels, Mark A. Feitelson	1999	57
10	Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon System Journal of Interferon & Cytokine Research ·Jonathan Larkin, Ling Jin, Mark W. Farmen, Daryl F. Venable, Ying Huang, Seng‐Lai Tan, John I. Glass	2003	56
11	Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers BMJ Open ·E.M. van Helvoort, W.E. van Spil, Mylène P. Jansen, Paco M J Welsing, M. Kloppenburg, M. Loef, Francisco J. Blanco, I.K. Haugen, Francis Bérenbaum, Jaume Bacardit, C. Ladel, John Loughlin, Anne‐Christine Bay‐Jensen, Ali Mobasheri, Jonathan Larkin, Janneke Boere, Harrie Weinans, Alain Lalande, A.C. Marijnissen, Floris P. J. G. Lafeber	2020	53
12	Determinants of Versican-V1 Proteoglycan Processing by the Metalloproteinase ADAMTS5 Journal of Biological Chemistry ·Simon J. Foulcer, Courtney M. Nelson, Maritza Quintero, Balagurunathan Kuberan, Jonathan Larkin, María T. Dours‐Zimmermann, Dieter R. Zimmermann, Suneel Apte	2014	49
13	Multi-classifier prediction of knee osteoarthritis progression from incomplete imbalanced longitudinal data Scientific Reports ·Paweł Widera, Paco M J Welsing, C. Ladel, John Loughlin, Floris P. F. J. Lafeber, Florence Petit Dop, Jonathan Larkin, Harrie Weinans, Ali Mobasheri, Jaume Bacardit	2020	48
14	Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice Hepatology ·Jonathan Larkin, Marcia M. Clayton, Jie Liu, Mark A. Feitelson	2001	43
15	Quantitation OF ARGS aggrecan fragments in synovial fluid, serum and urine from osteoarthritis patients Osteoarthritis and Cartilage ·Fiona Germaschewski, Christopher Matheny, Jonathan Larkin, F. Liu, Leenath Thomas, Joanne Saunders, Katherine Sully, Catherine Whittall, Y. Boyle, Gary Peters, N. Graham	2014	39
16	CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells The Journal of Immunology ·Jonathan Larkin, Gourapura J. Renukaradhya, Venkataraman Sriram, Wenjun Du, Jacquelyn Gervay‐Hague, Randy R. Brutkiewicz	2006	37
17	New Animal Models of Hepatitis B and C ILAR Journal ·Mark A. Feitelson, Jonathan Larkin	2001	33
18	Polyunsaturation in cell membranes and lipid bilayers and its effects on membrane proteins Lipids ·Simon J. Slater, Mary Beth Kelly, Mark D. Yeager, Jonathan Larkin, Cojen Ho, Christopher D. Stubbs	1996	32
19	Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction Lab on a Chip ·Robert M. Tona, Thomas McDonald, Nima Akhavein, Jonathan Larkin, David Lai	2019	27
20	Activation of fibronectin gene expression by hepatitis B virus x antigen Journal of Viral Hepatitis ·Pamela A. Norton, Helena Reis, Stuart Prince, Jonathan Larkin, Jonathan Pan, J. Liu, Qian Gong, Min Zhu, Mark A. Feitelson	2004	27

About Jonathan Larkin

Jonathan Larkin is a scholar working on Rheumatology, Complementary and Manual Therapy, Pharmacology, Immunology and Allergy and Anatomy, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (26 papers), Inflammatory mediators and NSAID effects (15 papers), Rheumatoid Arthritis Research and Therapies (10 papers), Hepatitis B Virus Studies (6 papers), Cell Adhesion Molecules Research (5 papers), Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Total Knee Arthroplasty Outcomes (4 papers). The work is most often cited by research in Rheumatology (603 citations), Hepatology (155 citations), Pharmacology (225 citations), Immunology and Allergy (77 citations) and Cancer Research (133 citations). Jonathan Larkin has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Ali Mobasheri, Anne‐Christine Bay‐Jensen, Cojen Ho, Mary Beth Kelly, Mark D. Yeager, Simon J. Slater, Christopher D. Stubbs, Frank J. Taddeo, Mark A. Feitelson and W.E. van Spil. Their work appears in journals such as Osteoarthritis and Cartilage, Journal of Biological Chemistry, Annals of the Rheumatic Diseases, Matrix Biology and Journal of Interferon & Cytokine Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact